1 Report Overview
1.1 Study Scope
1.2 Major Manufacturers Covered in This Report
1.3 Market Segment by Type
1.3.1 Global Intravenous Immunoglobulins Market Size Growth Rate by Type (2020-2025)
1.3.2 Neurology Intravenous Immunoglobulins
1.3.3 Hematology Intravenous Immunoglobulins
1.3.4 Immunology Intravenous Immunoglobulins
1.4 Market Segment by Application
1.4.1 Global Intravenous Immunoglobulins Market Share by Application (2020-2025)
1.4.2 Primary Immunodeficiency
1.4.3 Idiopathic Thrombocytopenic Purpura
1.4.4 Chronic Inflammatory Demyelinating Polyneuropathy
1.4.5 Kawasaki Disease
1.4.6 Guillain-Barre Syndrome
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Intravenous Immunoglobulins Market Size
2.1.1 Global Intravenous Immunoglobulins Revenue 2015-2025
2.1.2 Global Intravenous Immunoglobulins Sales 2015-2025
2.2 Intravenous Immunoglobulins Growth Rate by Regions
2.2.1 Global Intravenous Immunoglobulins Sales by Regions 2015-2019
2.2.2 Global Intravenous Immunoglobulins Revenue by Regions 2015-2019
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
3 Market Share by Manufacturers
3.1 Intravenous Immunoglobulins Sales by Manufacturers
3.1.1 Intravenous Immunoglobulins Sales by Manufacturers 2015-2019
3.1.2 Intravenous Immunoglobulins Sales Market Share by Manufacturers 2015-2019
3.2 Revenue by Manufacturers
3.2.1 Intravenous Immunoglobulins Revenue by Manufacturers (2015-2019)
3.2.2 Intravenous Immunoglobulins Revenue Share by Manufacturers (2015-2019)
3.2.3 Global Intravenous Immunoglobulins Market Concentration Ratio (CR5 and HHI)
3.3 Intravenous Immunoglobulins Price by Manufacturers
3.4 Key Manufacturers Intravenous Immunoglobulins Plants/Factories Distribution and Area Served
3.5 Date of Key Manufacturers Enter into Intravenous Immunoglobulins Market
3.6 Key Manufacturers Intravenous Immunoglobulins Product Offered
3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Sales and Revenue for Each Type
4.1.1 Neurology Intravenous Immunoglobulins Sales and Revenue (2015-2019)
4.1.2 Hematology Intravenous Immunoglobulins Sales and Revenue (2015-2019)
4.1.3 Immunology Intravenous Immunoglobulins Sales and Revenue (2015-2019)
4.2 Global Intravenous Immunoglobulins Sales Market Share by Type
4.3 Global Intravenous Immunoglobulins Revenue Market Share by Type
4.4 Intravenous Immunoglobulins Price by Type
5 Market Size by Application
5.1 Overview
5.2 Global Intravenous Immunoglobulins Sales by Application
6 United States
6.1 United States Intravenous Immunoglobulins Breakdown Data by Company
6.2 United States Intravenous Immunoglobulins Breakdown Data by Type
6.3 United States Intravenous Immunoglobulins Breakdown Data by Application
7 European Union
7.1 European Union Intravenous Immunoglobulins Breakdown Data by Company
7.2 European Union Intravenous Immunoglobulins Breakdown Data by Type
7.3 European Union Intravenous Immunoglobulins Breakdown Data by Application
8 China
8.1 China Intravenous Immunoglobulins Breakdown Data by Company
8.2 China Intravenous Immunoglobulins Breakdown Data by Type
8.3 China Intravenous Immunoglobulins Breakdown Data by Application
9 Rest of World
9.1 Rest of World Intravenous Immunoglobulins Breakdown Data by Company
9.2 Rest of World Intravenous Immunoglobulins Breakdown Data by Type
9.3 Rest of World Intravenous Immunoglobulins Breakdown Data by Application
9.4 Rest of World Intravenous Immunoglobulins Breakdown Data by Countries
9.4.1 Rest of World Intravenous Immunoglobulins Sales by Countries
9.4.2 Rest of World Intravenous Immunoglobulins Revenue by Countries
9.4.3 Japan
9.4.4 Korea
9.4.5 India
9.4.6 Southeast Asia
10 Company Profiles
10.1 CSL Behring
10.1.1 CSL Behring Company Details
10.1.2 Company Description and Business Overview
10.1.3 Sales, Revenue and Market Share of Intravenous Immunoglobulins
10.1.4 Intravenous Immunoglobulins Product Introduction
10.1.5 CSL Behring Recent Development
10.2 Grifols
10.2.1 Grifols Company Details
10.2.2 Company Description and Business Overview
10.2.3 Sales, Revenue and Market Share of Intravenous Immunoglobulins
10.2.4 Intravenous Immunoglobulins Product Introduction
10.2.5 Grifols Recent Development
10.3 Octapharma
10.3.1 Octapharma Company Details
10.3.2 Company Description and Business Overview
10.3.3 Sales, Revenue and Market Share of Intravenous Immunoglobulins
10.3.4 Intravenous Immunoglobulins Product Introduction
10.3.5 Octapharma Recent Development
10.4 Shire
10.4.1 Shire Company Details
10.4.2 Company Description and Business Overview
10.4.3 Sales, Revenue and Market Share of Intravenous Immunoglobulins
10.4.4 Intravenous Immunoglobulins Product Introduction
10.4.5 Shire Recent Development
10.5 ADMA Biologics
10.5.1 ADMA Biologics Company Details
10.5.2 Company Description and Business Overview
10.5.3 Sales, Revenue and Market Share of Intravenous Immunoglobulins
10.5.4 Intravenous Immunoglobulins Product Introduction
10.5.5 ADMA Biologics Recent Development
10.6 Bayer
10.6.1 Bayer Company Details
10.6.2 Company Description and Business Overview
10.6.3 Sales, Revenue and Market Share of Intravenous Immunoglobulins
10.6.4 Intravenous Immunoglobulins Product Introduction
10.6.5 Bayer Recent Development
10.7 Bharat Serum and Vaccines
10.7.1 Bharat Serum and Vaccines Company Details
10.7.2 Company Description and Business Overview
10.7.3 Sales, Revenue and Market Share of Intravenous Immunoglobulins
10.7.4 Intravenous Immunoglobulins Product Introduction
10.7.5 Bharat Serum and Vaccines Recent Development
10.8 Biotest
10.8.1 Biotest Company Details
10.8.2 Company Description and Business Overview
10.8.3 Sales, Revenue and Market Share of Intravenous Immunoglobulins
10.8.4 Intravenous Immunoglobulins Product Introduction
10.8.5 Biotest Recent Development
10.9 China Biologic Products
10.9.1 China Biologic Products Company Details
10.9.2 Company Description and Business Overview
10.9.3 Sales, Revenue and Market Share of Intravenous Immunoglobulins
10.9.4 Intravenous Immunoglobulins Product Introduction
10.9.5 China Biologic Products Recent Development
10.10 Hualan Biological Engineering
10.10.1 Hualan Biological Engineering Company Details
10.10.2 Company Description and Business Overview
10.10.3 Sales, Revenue and Market Share of Intravenous Immunoglobulins
10.10.4 Intravenous Immunoglobulins Product Introduction
10.10.5 Hualan Biological Engineering Recent Development
10.11 Kedrion Biopharma
10.12 LFB Group
10.13 Sanquin
11 Value Chain and Sales Channels Analysis
11.1 Value Chain Analysis
11.2 Sales Channels Analysis
11.2.1 Intravenous Immunoglobulins Sales Channels
11.2.2 Intravenous Immunoglobulins Distributors
11.3 Intravenous Immunoglobulins Customers
12 Market Forecast
12.1 Global Intravenous Immunoglobulins Sales and Revenue Forecast 2020-2025
12.2 Global Intravenous Immunoglobulins Sales Forecast by Type
12.3 Global Intravenous Immunoglobulins Sales Forecast by Application
12.4 Intravenous Immunoglobulins Forecast by Regions
12.4.1 Global Intravenous Immunoglobulins Sales Forecast by Regions 2020-2025
12.4.2 Global Intravenous Immunoglobulins Revenue Forecast by Regions 2020-2025
12.5 United States Market Forecast
12.6 European Union Market Forecast
12.7 China Market Forecast
12.8 Rest of World
12.8.1 Japan
12.8.2 Korea
12.8.3 India
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
